MDxHealth SA
MDXH
$1.60
$0.000.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 89.43% | 111.05% | 96.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 89.43% | 111.05% | 96.02% |
| Cost of Revenue | -- | -- | 47.26% | 63.73% | 67.74% |
| Gross Profit | -- | -- | 128.57% | 160.33% | 127.44% |
| SG&A Expenses | -- | -- | 34.59% | 46.32% | 53.02% |
| Depreciation & Amortization | -- | -- | 183.53% | -- | -- |
| Other Operating Expenses | -- | -- | 558.57% | 538.61% | 752.03% |
| Total Operating Expenses | -- | -- | 35.74% | 47.13% | 52.66% |
| Operating Income | -- | -- | 21.45% | 10.03% | -18.96% |
| Income Before Tax | -- | -- | 2.15% | -12.24% | -52.73% |
| Income Tax Expenses | -- | -- | -- | 200.00% | -- |
| Earnings from Continuing Operations | -- | -- | 2.14% | -12.93% | -52.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 2.14% | -12.93% | -52.73% |
| EBIT | -- | -- | 21.45% | 10.03% | -18.96% |
| EBITDA | -- | -- | 34.41% | 25.14% | -13.92% |
| EPS Basic | -- | -- | 38.70% | 19.24% | -23.18% |
| Normalized Basic EPS | -- | -- | 78.82% | 53.82% | -0.57% |
| EPS Diluted | -- | -- | 38.70% | 19.24% | -23.18% |
| Normalized Diluted EPS | -- | -- | 78.82% | 53.82% | -0.57% |
| Average Basic Shares Outstanding | -- | -- | 61.37% | 48.38% | 25.44% |
| Average Diluted Shares Outstanding | -- | -- | 61.37% | 48.38% | 25.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |